Correlation Between Poxel SA and Neovacs SA
Can any of the company-specific risk be diversified away by investing in both Poxel SA and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Poxel SA and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Poxel SA and Neovacs SA, you can compare the effects of market volatilities on Poxel SA and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Poxel SA with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Poxel SA and Neovacs SA.
Diversification Opportunities for Poxel SA and Neovacs SA
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Poxel and Neovacs is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Poxel SA and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Poxel SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Poxel SA are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Poxel SA i.e., Poxel SA and Neovacs SA go up and down completely randomly.
Pair Corralation between Poxel SA and Neovacs SA
Assuming the 90 days trading horizon Poxel SA is expected to under-perform the Neovacs SA. But the stock apears to be less risky and, when comparing its historical volatility, Poxel SA is 7.49 times less risky than Neovacs SA. The stock trades about -0.02 of its potential returns per unit of risk. The Neovacs SA is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 100,000,000 in Neovacs SA on October 9, 2024 and sell it today you would lose (99,999,896) from holding Neovacs SA or give up 100.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Poxel SA vs. Neovacs SA
Performance |
Timeline |
Poxel SA |
Neovacs SA |
Poxel SA and Neovacs SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Poxel SA and Neovacs SA
The main advantage of trading using opposite Poxel SA and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Poxel SA position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.Poxel SA vs. X Fab Silicon | Poxel SA vs. Affluent Medical SAS | Poxel SA vs. Impulse Fitness Solutions | Poxel SA vs. Jacquet Metal Service |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |